- Home
- NMM vs CRMD Comparison
NMM vs CRMD Comparison
Compare NMM & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMM
- CRMD
- Stock Information
- Founded
- NMM 2007
- CRMD 2006
- Country
- NMM Greece
- CRMD United States
- Employees
- NMM N/A
- CRMD N/A
- Industry
- NMM Marine Transportation
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- NMM Consumer Discretionary
- CRMD Health Care
- Exchange
- NMM Nasdaq
- CRMD Nasdaq
- Market Cap
- NMM 959.8M
- CRMD 973.3M
- IPO Year
- NMM 2007
- CRMD 2010
- Fundamental
- Price
- NMM $41.00
- CRMD $13.59
- Analyst Decision
- NMM Strong Buy
- CRMD Strong Buy
- Analyst Count
- NMM 1
- CRMD 6
- Target Price
- NMM $80.00
- CRMD $15.00
- AVG Volume (30 Days)
- NMM 88.6K
- CRMD 1.4M
- Earning Date
- NMM 05-07-2025
- CRMD 05-06-2025
- Dividend Yield
- NMM 0.49%
- CRMD N/A
- EPS Growth
- NMM N/A
- CRMD N/A
- EPS
- NMM 11.16
- CRMD 0.28
- Revenue
- NMM $1,319,623,000.00
- CRMD $82,553,827.00
- Revenue This Year
- NMM N/A
- CRMD $238.38
- Revenue Next Year
- NMM $7.93
- CRMD $53.52
- P/E Ratio
- NMM $3.61
- CRMD $50.72
- Revenue Growth
- NMM 0.28
- CRMD N/A
- 52 Week Low
- NMM $28.37
- CRMD $3.61
- 52 Week High
- NMM $65.89
- CRMD $15.38
- Technical
- Relative Strength Index (RSI)
- NMM 62.92
- CRMD 59.38
- Support Level
- NMM $39.87
- CRMD $13.83
- Resistance Level
- NMM $42.49
- CRMD $14.99
- Average True Range (ATR)
- NMM 1.07
- CRMD 0.66
- MACD
- NMM 0.06
- CRMD -0.08
- Stochastic Oscillator
- NMM 65.53
- CRMD 53.14
About NMM Navios Maritime Partners LP Common Units Representing Limited Partner Interests
Navios Maritime Partners LP is a seaborne shipping company. It owns and operates dry cargo and container vessels with the primary long-term and staggered expiration charters. The firm's fleet consists of Ultra- Handymax, Panamax, Capsize, and Container vessels and categorized in Drybulk and Container vessels. It earns revenue through the chartering of vessels and voyage contracts. Geographically, it generates majority revenue from Asia.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.